About Stroke Research
Clinical trials test or improve ways to understand, detect, prevent or treat diseases. A clinical trial may give you access to innovative therapies or technologies before they are available anywhere else. At Spectrum Health, we believe that research can offer hope and changes lives. As an academic teaching hospital, we participate in many national and international networks of research, connecting us to the lead medical centers in the nation. As a part of StrokeNet Network, we are bringing dedicated stroke research to the communities we serve and providing access to possible stroke therapies before they are available to the larger population.
We are actively participating in three categories: acute intervention registry, secondary prevention trial and stroke recovery trial. Click on the links, as well as discuss options with your doctor, to learn more
- Acute Intervention Registry: Mild and Rapidly Improving Stroke Study (MaRISS)
- Secondary Prevention Trial: Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
- Stroke Recovery Trial: HT-3951 vs. Placebo in Stroke Rehabilitation (RESTORE)